Contemporary Treatment of Amyloid Heart Disease

E-ISSN： 1873-4286|21|4|491-506

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.4, 2015-02, pp. : 491-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

-Amyloid Disrupting Drugs: Potential in the Treatment of Alzheimer's Disease

By Soto C.

CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite

Emerging &bgr;-Amyloid Therapies for the Treatment of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 9, Iss. 6, 2003-02 ,pp. : 427-447

Bentham Science Publishers

Access to resources Recommend Favorite

Disrupting &bgr;-Amyloid Aggregation for Alzheimer Disease Treatment

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 115-126

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD)

By Lukiw Walter J

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 255-271

Informa Healthcare

Access to resources Recommend Favorite

β-Amyloid peptide as a target for treatment of Alzheimer’s disease

By Conde Santiago

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite